2017
DOI: 10.1002/smll.201700703
|View full text |Cite
|
Sign up to set email alerts
|

Direct Reprogramming of Human Suspension Cells into Mesodermal Cell Lineages via Combined Magnetic Targeting and Photothermal Stimulation by Magnetic Graphene Oxide Complexes

Abstract: Suspension cells can provide a source of cells for cellular reprogramming, but they are difficult to transfect by nonviral vectors. An efficient and safe nonviral vector (GO-Fe O -PEI complexes) based on iron oxide nanoparticle (Fe O )-decorated graphene oxide (GO) complexed with polyethylenimine (PEI) for the first time is developed for delivering three individual episomal plasmids (pCXLE-hOCT3/4-shp53, pCXLE-hSK, and pCXLE-hUL) encoding pluripotent-related factors of Oct3/4, shRNA against p53, Sox2, Klf4, L-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 35 publications
(36 reference statements)
0
15
0
Order By: Relevance
“…In this context, nanoparticle-based drug delivery systems can be designed to pass biological barriers and to target cancerous cells, where they enter and accumulate to reach the drug therapeutic target, while, in the meantime, reducing its systemic toxicity [5,6]. Iron oxide nanoparticles proved to be suitable for such applications due to their biocompatibility for healthy tissues [7] and magnetic targeting ability [8,9]. Moreover, there are several FDA (Food and Drug Administration)-approved systems based on iron oxide nanoparticles for clinical use in cancer treatment through magnetic hyperthermia [10].…”
Section: Introductionmentioning
confidence: 99%
“…In this context, nanoparticle-based drug delivery systems can be designed to pass biological barriers and to target cancerous cells, where they enter and accumulate to reach the drug therapeutic target, while, in the meantime, reducing its systemic toxicity [5,6]. Iron oxide nanoparticles proved to be suitable for such applications due to their biocompatibility for healthy tissues [7] and magnetic targeting ability [8,9]. Moreover, there are several FDA (Food and Drug Administration)-approved systems based on iron oxide nanoparticles for clinical use in cancer treatment through magnetic hyperthermia [10].…”
Section: Introductionmentioning
confidence: 99%
“…As-prepared GO-PEG-OSA and PTX@GO-PEG-OSA NSs performed remarkable stability compared to the naked GO nanosheets in both water and FBS (Figure 1D; Supplementary les, Figure S1), which was attributed to the higher zeta potentials in contrast to GO and GO-PEG NSs (Figure 1B&C; Supplementary les, Figure S1). Furthermore, as GO-based nano-DDSs represent one of the promising nanomedicines to accomplish the photo-therapy, the photothermal conversion ability was tested by exposure of GO-PEG-OSA NSs and PTX@GO-PEG-OSA NSs (GO-PEG-OSA concentration ~0.1mg/mL) under 808 nm NIR laser irradiation [34]. Signi cant temperature increase (∼8°C and ∼13°C) was observed in GO-PEG-OSA group under NIR irradiation (1 W/cm 2 and 1.5 W/cm 2 ) and PTX@GO-PEG-OSA group showed similar photothermal conversion ability, while free PBS caused only a slight temperature increase (Figure 1G&H).…”
Section: Resultsmentioning
confidence: 99%
“…Notably, the cell transfection and reprogramming efficiency were significantly improved by the combined treatment of magnetic stirring and near-infrared photothermal stimulation. 189 Despite the fact that inorganic or hybrid nanoparticles are promising as reprogramming delivery carriers, there are still some critical issues that need to be addressed. First, the loading capability and stability of genes or drugs are limited to a certain extent by surface adsorption.…”
Section: Delivery Systems For Cell Reprogrammingmentioning
confidence: 99%